Question 1

What is Ubrogepant used for?

Accepted Answer

Ubrogepant (brand name Ubrelvy) is a CGRP Antagonist (Gepant) indicated for Acute Migraine.

Question 2

How does Ubrogepant work?

Accepted Answer

Ubrogepant works through the following mechanism: Oral CGRP receptor antagonist for acute migraine treatment without vasoconstrictive properties of triptans..

Question 3

What are the most common side effects of Ubrogepant?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for Ubrogepant. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is Ubrogepant the same as Ubrelvy?

Accepted Answer

Ubrelvy is a brand name for Ubrogepant. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

Ubrogepant

Mechanism of Action

Indications

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations